Allograft inflammatory factor-1: A pathogenetic factor for vasculitic neuropathy

Muscle and Nerve

Volumn 38, Issue 4, 2008, Pages 1272-1279

  Broglio, Laura ^a   Erne, Beat ^a   Tolnay, Markus ^b   Schaeren Wiemers, Nicole ^a   Fuhr, Peter ^a   Steck, Andreas J ^a   Renaud, Susanne ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

AIF 1; CIDP; Nerve inflammation; Vascular smooth muscle cells; Vasculitic neuropathy

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1;

ADULT; AGED; ARTICLE; BLOOD VESSEL INNERVATION; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NERVE BIOPSY; NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER;

ADULT; AGED; ARTERIES; BIOLOGICAL MARKERS; BIOPSY; CHEMOTAXIS, LEUKOCYTE; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM DISEASES; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; SURAL NERVE; UP-REGULATION; VASCULITIS;

EID: 53549091600     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21033     Document Type: Article

References (30)

1. Autieri MV, Carbone C, Mu A. Expression of allograft inflammatory factor-1 is a marker of activated human vascular smooth muscle cells and arterial injury. Arterioscler Thromb Vasc Biol 2000;20:1737-1744.
2. Autieri MV, Kelemen SE, Wendt KW. AIF-1 is an actin-polymerizing and Rac1-activating protein that promotes vascular smooth muscle cell migration. Circ Res 2003;92:1107-1114.
3. Beschorner R, Engel S, Mittelbronn M, Adjodah D, Dietz K, Schluesener HJ, et al. Differential regulation of the monocytic calcium-binding peptides macrophage-inhibiting factor related protein-8 (MRP8/S100A8) and allograft inflammatory factor-1 (AIF-1) following human traumatic brain injury. Acta Neuropathol (Berl) 2000;100:627-634.
4. Cornblath DR, Asbury AK, Albers JW, Feasby TE, Hahn AF, McLeod JG, et al. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991;41:617-618.
5. Deininger MH, Seid K, Engel S, Meyermann R, Schluesener HJ. Allograft inflammatory factor-1 defines a distinct subset of infiltrating macrophages/microglial cells in rat and human gliomas. Acta Neuropathol (Berl) 2000;100:673-680.
6. Deininger MH, Weinschenk T, Meyermann R, Schluesener HJ. The allograft inflammatory factor-1 in Creutzfeldt-Jakob disease brains. Neuropathol Appl Neurobiol 2003;29:389-399.
7. Del Galdo F, Maul G, Jiménez SA, Artlett CM. Expression of allograft inflammatory factor 1 in tissues from patients with systemic sclerosis and in vitro differential expression of its isoforms in response to transforming growth factor β. Arthritis Rheum 2006;54:2616-2625.
8. Jennette JC, Falk RJ. Nosology of primary vasculitis. Curr Opin Rheumatol 2007;19:10-16.
9. Kelemen SE, Autieri MV. Expression of allograft inflammatory factor-1 in T lymphocytes: a role in T-lymphocyte activation and proliferative arteriopathies. Am J Pathol 2005;167: 619-626.
10. Kiefer R, Kieseier BC, Stoll G, Hartung HP. The role of macrophages in immune-mediated damage to the peripheral nervous system. Prog Neurobiol 2001;64:109-127.
11. Kieseier BC, Kiefer R, Gold R, Hemmer B, Willison HJ, Hartung HP. Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle Nerve 2004;30:131-156.
12. Kimura M, Kawahito Y, Obayashi H, Ohta M, Hara H, Adachi T, et al. A critical role for allograft inflammatory factor-1 in the pathogenesis of rheumatoid arthritis. J Immunol 2007; 178:3316-3322.
13. Kissel JT, Collins MP, Mendell JR. Vasculitic neuropathy. In: Mendell JR, Kissel JT, Cornblath DR, editors. Diagnosis and management of peripheral nerve disorders. New York: Oxford University Press; 2001. p 202-225.
14. Leppert D, Hughes P, Huber S, Erne B, Grygar C, Said G, et al. Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy. Neurology 1999;53:62-70.
15. Moore PM. Vasculitic neuropathies. JNNP 2000;68:271-276.
16. Panegyres PK, Faull RJ, Russ GR, Appleton SL, Wangel AG, Blumbergs PC. Endothelial cell activation in vasculitis of peripheral nerve and skeletal muscle. JNNP 1992;55:4-7.
17. Postler E, Rimner A, Beschorner R, Schluesener HJ, Meyermann R. Allograft inflammatory factor-1 is upregulated in microglial cells in human cerebral infarctions. J Neuroimmunol 2000;108:244-250.
18. Renaud S, Hays AP, Brannagan TH III, Sander HW, Edgar M, Weimer LH, et al. Gene expression profiling in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 2005;159:203-214.
19. Rolfe BE, Campbell JH, Smith NJ, Cheong W, Campbell GR. T lymphocytes affect smooth muscle cell phenotype and proliferation. Arterioscler Thromb Vasc Biol 1995;15:1204-1210.
20. Said G, Lacroix C. Primary and secondary vasculitic neuropathy. J Neurol 2005;252:633-641.
21. Satoi H, Oka N, Kawasaki T, Miyamoto K, Akiguchi I, Kimura J. Mechanisms of tissue injury in vasculitic neuropathies. Neurology 1998;50:492-496.
22. Schluesener HJ, Seid K, Kretzschmar J, Meyermann R. Allograft inflammatory factor-1 in rat experimental autoimmune encephalomyelitis, neuritis, and uveitis: expression by activated macrophages and microglial cells. Glia 1998;24:244-251.
23. Schröder JM. Proliferation of epineurial capillaries and smooth muscle cells in angiopathic peripheral neuropathy. Acta Neuropathol (Berl) 1986;72:29-37.
24. Schütz G, Schröder JM. Number and size of epineurial blood vessels in normal and diseased human sural nerves. Cell Tissue Res 1997;290:31-37.
25. Sibinga NE, Feinberg MW, Yang H, Werner F, Jain MK. Macrophage-restricted and interferon gamma-inducible expression of the allograft inflammatory factor-1 gene requires Pu.1. J Biol Chem 2002;277:16202-16210.
26. Tian Y, Autieri M. Cytokine expression and AIF-1-mediated activation of Rac2 in vascular smooth muscle cells: a role for Rac2 in VSMC activation. Am J Physiol Cell Physiol 2007;292: C841-C849.
27. Utans U, Arceci RJ, Yamashita Y, Russell ME. Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection. J Clin Invest 1995;95:2954-2962.
28. Utans U, Quist WC, McManus BM, Wilson JE, Arceci RJ, Wallace AF, et al. Allograft inflammatory factory-1. A cytokine-responsive macrophage molecule expressed in transplanted human hearts. Transplantation 1996;61:1387-1392.
29. Van Rhijn I, Van den Berg LH, Bosboom WM, Otten HG, Logtenberg T. Expression of accessory molecules for T-cell activation in peripheral nerve of patients with CTDP and vasculitic neuropathy. Brain 2000;123:2020-2029.
30. Yang ZF, Ho DW, Lau CK Lam CT, Lum CT, Poon RT, et al. Allograft inflammatory factor-1 (AIF-1) is crucial for the survival and pro-inflammatory activity of macrophages. Int Immunol 2005;17:1391-1397.